ES2054017T3 - Metodo para combatir pneumocystis carinii. - Google Patents

Metodo para combatir pneumocystis carinii.

Info

Publication number
ES2054017T3
ES2054017T3 ES89309257T ES89309257T ES2054017T3 ES 2054017 T3 ES2054017 T3 ES 2054017T3 ES 89309257 T ES89309257 T ES 89309257T ES 89309257 T ES89309257 T ES 89309257T ES 2054017 T3 ES2054017 T3 ES 2054017T3
Authority
ES
Spain
Prior art keywords
combat
pneumocystis carinii
carinii
treatment
pneuwocistis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89309257T
Other languages
English (en)
Inventor
Dennis M Schmatz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2054017T3 publication Critical patent/ES2054017T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

ESTA DESCRITO UN METODO PARA EL TRATAMIENTO DE PNEUWOCISTIS CARINII, AGENTE CAUSANTE DE LA NEUMONIA DE PARTICULAR GRAVEDAD PARA PACIENTES AFECTADOS CON EL SINDROME DE INMUNODEFICIENCIA ADQUIRIDA (SIDA) MEDIANTE LA ADMINISTRACION DE UN COMPONENTE CICLOHEXAPEPTIDO HIPOFILICO. LAS COMPOSICIONES APTAS PARA EL TRATAMIENTO DE P. CARINII TAMBIEN ESTAN DESCRITAS.
ES89309257T 1988-09-12 1989-09-12 Metodo para combatir pneumocystis carinii. Expired - Lifetime ES2054017T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24276788A 1988-09-12 1988-09-12
US24604288A 1988-09-16 1988-09-16
US39888989A 1989-08-30 1989-08-30

Publications (1)

Publication Number Publication Date
ES2054017T3 true ES2054017T3 (es) 1994-08-01

Family

ID=27399603

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89309257T Expired - Lifetime ES2054017T3 (es) 1988-09-12 1989-09-12 Metodo para combatir pneumocystis carinii.

Country Status (7)

Country Link
EP (1) EP0359529B1 (es)
JP (1) JPH0725692B2 (es)
CA (1) CA1333150C (es)
DE (1) DE68905119T2 (es)
DK (1) DK173802B1 (es)
ES (1) ES2054017T3 (es)
IE (1) IE892924L (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020063A1 (en) * 1989-06-30 1990-12-31 Robert A. Giacobbe Antibiotic agent
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
US5366880A (en) * 1990-12-19 1994-11-22 Merck & Co., Inc. Antibiotic agent
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
TW199162B (es) * 1991-05-09 1993-02-01 Fujisawa Pharmaceutical Co
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
ATE140460T1 (de) * 1991-10-17 1996-08-15 Merck & Co Inc Echinocandin-b-derivat
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
GB9506372D0 (en) * 1995-03-29 1995-05-17 Fujisawa Pharmaceutical Co New peptide compounds
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
AU765660B2 (en) 1998-08-20 2003-09-25 Eli Lilly And Company Ring modified cyclic peptide analogs
BR9916101A (pt) 1998-12-09 2002-06-04 Lilly Co Eli Purificação de compostos de ciclopeptìdeos equinocandinos
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
CA2362016A1 (en) 1999-03-03 2000-09-08 Kenneth Philip Moder Echinocandin/carbohydrate complexes
EP1582204B1 (en) 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
KR20010112302A (ko) 1999-03-03 2001-12-20 피터 지. 스트링거 제약학적 경구용 ｅｃｂ 조제물 및 조성물의 제조 방법
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803581A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Derivate des tetrahydro-echinocandin b
CA1183127A (en) * 1979-12-13 1985-02-26 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
EP0311193B1 (en) * 1987-10-07 1993-12-01 Merck & Co. Inc. Antifungal fermentation product
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product

Also Published As

Publication number Publication date
DK446389A (da) 1990-03-13
EP0359529A1 (en) 1990-03-21
DE68905119T2 (de) 1993-08-26
IE892924L (en) 1990-03-12
JPH0725692B2 (ja) 1995-03-22
JPH02288837A (ja) 1990-11-28
EP0359529B1 (en) 1993-03-03
CA1333150C (en) 1994-11-22
DK446389D0 (da) 1989-09-11
DE68905119D1 (de) 1993-04-08
DK173802B1 (da) 2001-11-05

Similar Documents

Publication Publication Date Title
ES2054017T3 (es) Metodo para combatir pneumocystis carinii.
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
ES2103262T3 (es) Procedimiento de fotoestructuracion.
ES8201596A1 (es) Procedimiento de obtencion de mucopolisacaridos
KR930023370A (ko) 단백질 씨(c) 유도체
KR890011606A (ko) 항응고제
NO990916D0 (no) Bruk av GLP-1 eller analoger i behandlingen av myokardialt infarkt
ATE72629T1 (de) Cyclosporin enthaltende pharmazeutische zubereitung.
ATE81135T1 (de) Aktive thymopentin-analoga.
ATE160941T1 (de) Sulfatierte polysaccharide mit antimetastasenwirkung
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
ES2146199T3 (es) Utilizacion de la arginina como inmunoestimulante.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2119165T3 (es) Nueva actividad de cofactor anticoagulante.
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
ES2057413T3 (es) Agente antibiotico.
ES2174838T3 (es) Metodo para aumentar la absorcion del intestino.
ES2055163T3 (es) Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion.
ITRM910673A1 (it) Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle.
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
KR910001040A (ko) 항응고요법을 위한 활성물질인 암블리옴민
ES2145114T3 (es) Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias.
ES2062120T3 (es) Nuevas n-(aril substituido)-n'-(alcoxi substituido)-ureas y tioureas como agentes anticolesterolemicos y antiateroscleroticos.
SE7701441L (sv) Nytt piperazinyluracilsalt
ES2076248T3 (es) Dibenzofuranos substituidos y metodos para el uso de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 359529

Country of ref document: ES